Lynne Sullivan
Director of Finance/CFO chez UNITY BIOTECHNOLOGY, INC.
Fortune : 53 053 $ au 30/04/2024
Postes actifs de Lynne Sullivan
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SOLID BIOSCIENCES INC. | Director/Board Member | 01/11/2015 | - |
| Independent Dir/Board Member | 01/11/2015 | - | |
| INOZYME PHARMA, INC. | Director/Board Member | 01/05/2020 | - |
| Independent Dir/Board Member | 01/05/2020 | - | |
| UNITY BIOTECHNOLOGY, INC. | Director of Finance/CFO | 01/08/2020 | - |
| Comptroller/Controller/Auditor | 02/10/2020 | - | |
Bioverativ Therapeutics, Inc.
 Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Director/Board Member | - | - |
BiomX Ltd.
 BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Director/Board Member | - | - |
| Inheris Pharmaceuticals, Inc. | Director/Board Member | - | - |
Historique de carrière de Lynne Sullivan
Anciens postes connus de Lynne Sullivan
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BIOMX INC. | Director/Board Member | 28/10/2019 | 15/03/2024 |
| Independent Dir/Board Member | 28/10/2019 | 15/03/2024 | |
| ADICET BIO, INC. | Director/Board Member | 01/12/2017 | 15/09/2020 |
| Independent Dir/Board Member | 01/12/2017 | 15/09/2020 | |
Compass Therapeutics LLC
 Compass Therapeutics LLC BiotechnologyHealth Technology Compass Therapeutics LLC operates as a healthcare industry focusing on biotechnology. It offers drug discovery, development, biologics, oncology and immuno-oncology. The company was founded by Errik B. Anderson and Thomas J. Schuetz in 2014 and is headquartered in Cambridge, MA. | Director of Finance/CFO | 01/12/2018 | 01/08/2019 |
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░ ░░░░░░░░ ░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | - | - |
Formation de Lynne Sullivan
| Bentley University | Graduate Degree |
| Suffolk University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 14 |
| Israël | 3 |
| Allemagne | 2 |
Opérationnelle
| Director/Board Member | 8 |
| Independent Dir/Board Member | 4 |
| Comptroller/Controller/Auditor | 4 |
Sectorielle
| Health Technology | 12 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 6 |
|---|---|
| BIOGEN INC. | Health Technology |
| MERCK KGAA | Health Technology |
| UNITY BIOTECHNOLOGY, INC. | Health Technology |
| SOLID BIOSCIENCES INC. | Health Technology |
| INOZYME PHARMA, INC. | Health Technology |
| BIOMX INC. | Health Technology |
| Entreprise privées | 8 |
|---|---|
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Health Technology |
Compass Therapeutics LLC
Compass Therapeutics LLC BiotechnologyHealth Technology Compass Therapeutics LLC operates as a healthcare industry focusing on biotechnology. It offers drug discovery, development, biologics, oncology and immuno-oncology. The company was founded by Errik B. Anderson and Thomas J. Schuetz in 2014 and is headquartered in Cambridge, MA. | Health Technology |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
| Arthur Anderson & Co. | |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Health Technology |
resTORbio, Inc.
 resTORbio, Inc. BiotechnologyHealth Technology resTORbio, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development and commercialization of medicines for aging-related diseases and conditions. It offers an immunotherapy under the TORC1 program. The company was founded by Chen Schor and Joan Mannick on July 5, 2016 and is headquartered in Boston, MA. | Health Technology |
| Inheris Pharmaceuticals, Inc. | |
KJT Group, Inc.
 KJT Group, Inc. Miscellaneous Commercial ServicesCommercial Services KJT Group, Inc. is an evidence-based research and consulting firm. The private company is based in Rochester, NY. The company was founded in 2007 by Kenneth Tomaszewski. Michaela Gascon has been the CEO of the company since 2007. | Commercial Services |
- Bourse
- Insiders
- Lynne Sullivan
- Expérience
